Brand/Generic Settlements Return To Capitol Hill
This article was originally published in The Pink Sheet Daily
Executive Summary
Apotex could make its case for scrapping first-to-file exclusivity during a hearing in Rep. Rush’s subcommittee.
You may also be interested in...
Brand/Generic Settlement Bill May Need Help From Authorized Generics Limits
Supporters of legislation to curb settlements between brand and generic firms may consider modifying their proposal to include limits on authorized generics to garner more support
Brand/Generic Settlement Bill May Need Help From Authorized Generics Limits
Supporters of legislation to curb settlements between brand and generic firms may consider modifying their proposal to include limits on authorized generics to garner more support
FTC Chairman To Be Jon Leibowitz: Will Reverse Payments Get More Scrutiny?
Jon Leibowitz, a fierce opponent of reverse settlements between brand name and generic companies, is set to head the Federal Trade Commission